Bengt Källén (Former)
1 – 10 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Drugs during pregnancy : Methodological aspects
2016)(
- Book/Report › Book
- 2015
-
Mark
Use of tramadol in early pregnancy and congenital malformation risk.
(
- Contribution to journal › Article
- 2014
-
Mark
Maternal hypothyroidism in early pregnancy and infant structural congenital malformations.
(
- Contribution to journal › Article
-
Mark
Fetal safety of erythromycin. An update of Swedish data.
(
- Contribution to journal › Article
-
Mark
Maternal obesity and risk of Down syndrome in the offspring
(
- Contribution to journal › Article
-
Mark
Antiobesity drugs in early pregnancy and congenital malformations in the offspring.
(
- Contribution to journal › Article
-
Mark
Risk of neurodisability and other long-term outcomes for infants born following assisted reproductive technologies.
(
- Contribution to journal › Scientific review
-
Mark
Use of ondansetron during pregnancy and congenital malformations in the infant.
(
- Contribution to journal › Article
-
Mark
Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring.
(
- Contribution to journal › Article
- 2013
-
Mark
Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
(
- Contribution to journal › Article